← All companies
CTOR
Citius Oncology, Inc.
$0.63
+0.05 +8.95%
Key statistics
from XBRL data in SEC filingsMarket cap
$58.2M
Revenue (TTM)
—
Net income (TTM)
-$42.5M
EPS (TTM)
$-0.47
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$2.63M
Total assets
$101M
Gross margin
—
52-week range
$0.49 – $2.25
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 1, 2026
8-K
Results of operations (earnings release)
May 15, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events
May 6, 2026
8-K
Other events
Apr 29, 2026
8-K
Delisting notice or listing-rule failure
Apr 28, 2026
8-K
Other events
Mar 31, 2026
8-K
Other events
Mar 10, 2026
8-K
Other events
Mar 4, 2026
8-K
Results of operations (earnings release)
Feb 13, 2026
10-Q
Quarter ended 2025-12-31
Feb 13, 2026
8-K
Results of operations (earnings release)
Dec 23, 2025
10-K
Fiscal year ended 2025-09-30
Dec 23, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Dec 10, 2025
8-K
Regulation FD disclosure; Other events
Dec 1, 2025
8-K
Director or officer change; Shareholder vote results
Oct 27, 2025
8-K
Regulation FD disclosure
Oct 23, 2025
8-K
Unregistered sale of equity; Director or officer change
Sep 19, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Sep 10, 2025
8-K
Other events
Aug 18, 2025
8-K
Results of operations (earnings release)
Aug 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Entered a material agreement; Other events
Jul 18, 2025
8-K
Other events
Jun 27, 2025
8-K
Other events
Jun 17, 2025
10-Q
Quarter ended 2025-03-31
May 14, 2025
8-K
Results of operations (earnings release)
May 14, 2025
8-K
Delisting notice or listing-rule failure
Apr 25, 2025
8-K
Entered a material agreement
Apr 3, 2025
8-K
Other events
Feb 14, 2025
10-Q
Quarter ended 2024-12-31
Feb 14, 2025
8-K
Other events
Feb 6, 2025
10-K/A
Fiscal year ended 2024-09-30
Jan 27, 2025
8-K
Other events
Jan 7, 2025
8-K
Other events
Jan 6, 2025
8-K
Results of operations (earnings release)
Dec 27, 2024
10-K
Fiscal year ended 2024-09-30
Dec 27, 2024
8-K
Other events
Nov 12, 2024
8-K
Entered a material agreement
Sep 13, 2024
8-K
Other events
Sep 5, 2024